Henan Lingrui Pharmaceutical Co (SHSE:600285) Total Stockholders Equity : ¥2,934 Mil (As of Mar. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Henan Lingrui Pharmaceutical Co Total Stockholders Equity?

Henan Lingrui Pharmaceutical Co's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ¥2,934 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Henan Lingrui Pharmaceutical Co's Book Value per Share for the quarter that ended in Mar. 2024 was ¥5.17. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Henan Lingrui Pharmaceutical Co's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.01.

Henan Lingrui Pharmaceutical Co Total Stockholders Equity Historical Data

The historical data trend for Henan Lingrui Pharmaceutical Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Henan Lingrui Pharmaceutical Co Total Stockholders Equity Chart

Henan Lingrui Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

2,209.89

2,312.72

2,278.99

2,550.81

2,791.04

Henan Lingrui Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial															2,698.99	2,542.57	2,711.12	2,791.04	2,934.07

Henan Lingrui Pharmaceutical Co (SHSE:600285) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Henan Lingrui Pharmaceutical Co's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(2934.068	-	0)	/	567.14
	=	5.17

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Henan Lingrui Pharmaceutical Co's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(29.007	+	7.248)	/	2934.068
	=	0.01

Henan Lingrui Pharmaceutical Co Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Henan Lingrui Pharmaceutical Co's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Henan Lingrui Pharmaceutical Co (SHSE:600285) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Henan Lingrui Pharmaceutical Co Ltd (SHSE:600285) » Definitions » Total Stockholders Equity

Traded in Other Exchanges

N/A

Address

No. 59 Jiefang Chengguan Road, Xinxian, Xinyang, Henan, CHN, 465550

Website

http://www.lingrui.com

Henan Lingrui Pharmaceutical Co Ltd is a Chinese company engaged in the development, production, and distribution of pharmaceuticals. The Company's products include tablets, capsules, injections and other medicines.

Executives

Wu Xi Zhen	Director
Li Jin	Supervisors
Ye Qiang	senior management
Chen Yan	Directors, senior managers
Wu Hui Bin	senior management
Yu Peng	Director
Zhao Zhi Jun	Director
Li Lei	senior management
Feng Guo Xin	Directors, senior managers
Pan Zi Run	Director
Xiong Wei Zheng	Director
Tang Wei	Supervisors
Cheng Jian Jun	Director
Zhang Jun Bing	Director
Xia Hui	senior management

Henan Lingrui Pharmaceutical Co (SHSE:600285) Headlines

No Headlines